District Business Manager, Cardiovascular - Atlanta, GA at Bristol-Myers Squibb

United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Leadership skills to inspire and motivate a team of 6-10 TASs to exceed business goals
Expertise in coaching TASs on selling skills, scientific engagement, and digital capabilities
Ability to drive adoption of BMS Cardiovascular portfolio and generate demand
Proficiency in business and account planning
Knowledge of new digital tools and capabilities (e.g., Medical on Call, CE^3)
Collaborative skills to work across Commercial, Medical, and Access organizations (e.g., with SEP, FAM)
Field-based role requiring 100% time in the field with TASs

Responsibilities

Lead, coach, and motivate a team of approximately 6-10 TASs to drive adoption of Cardiovascular portfolio and generate demand
Conduct focused in-role coaching on competencies like scientific agility, customer/commercial mindset, change agility, and teamwork/enterprise mindset (e.g., ride-alongs with key HCPs)
Own TASs' learning journey and ensure continuous improvement in core skills (e.g., scientific agility, patient mindset, digital agility, analytical mindset)
Champion adoption of new capabilities and tools (e.g., CE^3 analytics, content personalization) by role modeling and sharing knowledge
Participate in business and account planning
Collaborate with matrix partners (e.g., SEP, FAM) to address customer needs and meet sales targets
Report to the Regional Business Director

Skills

Sales Leadership

Team Coaching

HCP Engagement

Pharmaceutical Sales

Performance Management

Customer Engagement

Business Development

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free